Indication
Fetal Hemoglobin
3 clinical trials
4 products
3 drugs
Clinical trial
Phase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood Stem Cell (PBSC) Transplantation for Children and Adults With Hematological MalignanciesStatus: Recruiting, Estimated PCD: 2027-11-30
Drug
fludarabineProduct
BusulfanDrug
MelphalanDrug
VarlilumabProduct
LevetiracetamClinical trial
Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta ThalassemiaStatus: Recruiting, Estimated PCD: 2025-04-22
Product
ThalidomideClinical trial
Long Term Comparison of Combination Therapy (Thalidomide and Hydroxyurea) vs Thalidomide Alone in Beta Thalassemia.Status: Active (not recruiting), Estimated PCD: 2024-04-01
Product
Thalidomide + Hydroxyurea